CN110547461A - 一种沙棘白刺藜麦代餐粉及其制备方法 - Google Patents
一种沙棘白刺藜麦代餐粉及其制备方法 Download PDFInfo
- Publication number
- CN110547461A CN110547461A CN201910776238.6A CN201910776238A CN110547461A CN 110547461 A CN110547461 A CN 110547461A CN 201910776238 A CN201910776238 A CN 201910776238A CN 110547461 A CN110547461 A CN 110547461A
- Authority
- CN
- China
- Prior art keywords
- powder
- quinoa
- nitraria tangutorum
- buckthorn
- nitraria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 113
- 240000006162 Chenopodium quinoa Species 0.000 title claims abstract description 55
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 53
- 235000012054 meals Nutrition 0.000 title claims abstract description 36
- 240000000171 Crataegus monogyna Species 0.000 title claims description 5
- 235000013175 Crataegus laevigata Nutrition 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 240000000950 Hippophae rhamnoides Species 0.000 title abstract 4
- 241001104824 Nitraria tangutorum Species 0.000 claims abstract description 59
- 244000068988 Glycine max Species 0.000 claims abstract description 52
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 52
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 49
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 31
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 31
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 29
- 229920001202 Inulin Polymers 0.000 claims abstract description 17
- 235000010582 Pisum sativum Nutrition 0.000 claims abstract description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 17
- 229940029339 inulin Drugs 0.000 claims abstract description 17
- 240000004713 Pisum sativum Species 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000007558 Avena sp Nutrition 0.000 claims abstract description 8
- 240000005979 Hordeum vulgare Species 0.000 claims abstract 6
- 241000209763 Avena sativa Species 0.000 claims abstract 2
- 241000229143 Hippophae Species 0.000 claims description 101
- 235000003935 Hippophae Nutrition 0.000 claims description 52
- 241000219843 Pisum Species 0.000 claims description 36
- 239000002245 particle Substances 0.000 claims description 36
- 235000005072 Vigna sesquipedalis Nutrition 0.000 claims description 35
- 235000021278 navy bean Nutrition 0.000 claims description 35
- 244000075850 Avena orientalis Species 0.000 claims description 29
- 238000002156 mixing Methods 0.000 claims description 23
- 239000002131 composite material Substances 0.000 claims description 18
- 241000159206 Nitraria Species 0.000 claims description 16
- 238000000227 grinding Methods 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 11
- 230000001007 puffing effect Effects 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000001694 spray drying Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 238000004537 pulping Methods 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 235000021028 berry Nutrition 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 10
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 150000004676 glycans Chemical class 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 229920001282 polysaccharide Polymers 0.000 abstract description 5
- 239000005017 polysaccharide Substances 0.000 abstract description 5
- 230000036186 satiety Effects 0.000 abstract description 5
- 235000019627 satiety Nutrition 0.000 abstract description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 4
- 235000019577 caloric intake Nutrition 0.000 abstract 1
- 241000209219 Hordeum Species 0.000 description 23
- 238000003756 stirring Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 229920002774 Maltodextrin Polymers 0.000 description 12
- 239000005913 Maltodextrin Substances 0.000 description 12
- 229940035034 maltodextrin Drugs 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 239000011812 mixed powder Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 235000016709 nutrition Nutrition 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 208000008589 Obesity Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 235000020824 obesity Nutrition 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 239000002002 slurry Substances 0.000 description 9
- 239000007921 spray Substances 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 238000010411 cooking Methods 0.000 description 6
- 239000011552 falling film Substances 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000011344 liquid material Substances 0.000 description 6
- 239000011268 mixed slurry Substances 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000037221 weight management Effects 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 244000298479 Cichorium intybus Species 0.000 description 3
- 235000007542 Cichorium intybus Nutrition 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 229930013930 alkaloid Chemical group 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 150000002333 glycines Chemical class 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000005496 tempering Methods 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 108090001061 Insulin Chemical group 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229930003935 flavonoid Chemical group 0.000 description 2
- 150000002215 flavonoids Chemical group 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000015493 Chenopodium quinoa Nutrition 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000001748 Hyperlipoproteinemia Type V Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Chemical group 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical group 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明中公开了一种沙棘白刺藜麦代餐粉,由以下原料组成:沙棘鲜果、白刺果、藜麦、青稞、燕麦、豌豆、黄豆和菊粉;本发明还提供了沙棘白刺藜麦代餐粉的制备方法。本发明能够增加食物中的膳食纤维、不饱和脂肪酸、植物多糖等,能提高食用者的饱腹感,控制能量摄入,进而较好地管理体重,提升健康水平。
Description
技术领域
本发明涉及代餐粉领域,尤其涉及一种沙棘白刺藜麦代餐粉及其制备方法。
背景技术
随着人民生活水平的日益提高,整个社会的结构性营养过剩导致全国有4 亿人体重超标。世卫组织发出警告:超重和肥胖是全球引起死亡的第五大风险, 全球每年“胖死”的人至少280万。中国肥胖人口已达9000万,占比超过美国位居世界第一,成为全球肥胖人口最多的国家。目前,社会性的肥胖已经使中国成为全球第一高血压大国、第一糖尿病大国、第一高血脂大国、第一高尿酸大国。而肥胖症患者通常都有非常严重的胃肠功能方面的疾病,比如肠道垃圾堵塞,长期严重便秘,而胃肠功能紊乱进一步加重肥胖病症,形成恶性循环。
20世纪80年代,美国著名营养学家柯林·坎贝尔主持了有美国康奈尔大学、英国牛津大学、中国医学科学院、中国疾病预防控制中心联合参与的一项饮食结构差异对身体健康的影响的研究课题,整理综合了836篇营养学和流行病学研究文献,科学系统地阐述了纯植物食物膳食结构在预防和治疗慢性疾病方面的重要作用。
坎贝尔教授指出:第一,营养学是解决人类健康问题的万能钥匙;第二,我们大多数人眼中的营养——实际上根本就不营养。这就意味着我们必须改变工业化时代遗留下来的不科学的营养观念,代之以符合人类真正需求的面向第四次工业革命的全新营养观念。虽然现代营养科学为人类提供了完善的营养知识体系,但是来自于生物多样性的生物活性物质缺失使人类的营养结构存在潜在风险。
替代性饮食(代餐食品)是健康保护的重要手段。目前,医学界和营养界对于代餐食品的作用机理已经有了比较深入的认识,健康管理行业和一些食品企业也推出了一些体重管理食品(代餐食品)。但是这些代餐食品也有一些局限性。主要是这些代餐食品的营养结构并不十分合理,不能合理的限制碳水化合物和脂肪的摄入,因此无法有效的增加食用者的饱腹感,不能很好的帮助食用者进行体重管理。
发明内容
本发明的目的在于解决现有技术中存在的以上问题,提供一种沙棘白刺藜麦代餐粉及其制备方法,本发明的代餐粉能有效的增加食用者的饱腹感,从而很好的帮助食用者进行体重管理。
为解决上述技术问题,本发明采用的技术方案如下:
一种沙棘白刺藜麦代餐粉,由以下原料组成:沙棘鲜果、白刺果、藜麦、青稞、燕麦、豌豆、黄豆和菊粉。
优选地,由以下重量份的原料组成:沙棘鲜果4-30份,白刺果5-15份,藜麦15-35份,青稞5-15份,燕麦3-8份,豌豆8-15份,黄豆8-15份,菊粉 2-5份。
一种沙棘白刺藜麦代餐粉的制备方法,包括以下步骤:
A、按照重量份称取各原料组分;
B、将沙棘鲜果打浆,压榨,过滤得到沙棘果浆和沙棘籽皮;将沙棘果浆浓缩,喷雾干燥,得到沙棘果粉;
C、将白刺干果浸泡复水,压榨,均质,过滤,得到白刺果浆和白刺籽皮;将白刺果浆浓缩,冷冻干燥并粉碎,得到白刺果粉;
D、将步骤B中的沙棘籽皮和步骤C中的白刺籽皮混合进行干燥,超微粉碎,得到沙棘白刺复合膳食纤维粉;
E、将藜麦磨浆,高压蒸煮,喷雾干燥,得到藜麦熟化粉;
F、将青稞和燕麦混合后粉碎,将粉碎后的混合物膨化加工,获得混合膨化粉,再粉碎成粒径为40-60微米的青稞燕麦混合膨化粉;
G、将黄豆和豌豆混合,浸泡,磨浆,均质,过滤,得到豌豆黄豆混合浆和豌豆黄豆混合渣;将豌豆黄豆混合浆喷雾干燥,得到粒径为30-40微米的豌豆黄豆复合速溶粉;将豌豆黄豆混合渣微波干燥,超微粉碎,得到粒径为10-20 微米的豌豆黄豆膳食纤维粉;
H、将步骤B中的沙棘果粉、步骤C中的白刺果粉、步骤D中的沙棘白刺复合膳食纤维粉、步骤E中的藜麦熟化粉、步骤F中的青稞燕麦混合膨化粉、步骤G中的豌豆黄豆膳食纤维粉与菊粉混合均匀,制得沙棘白刺藜麦代餐粉。
本发明的代餐粉中的主要原料是沙棘鲜果、白刺果、藜麦,以青稞、燕麦、豌豆、黄豆和菊粉为辅助原料制成。
沙棘的叶、皮、果实及种子在医药上有着特殊效能。沙棘果能够活血散淤、化痰舒胸、补脾健胃,还能治疗跌打损伤、淤肿、咳嗽、呼吸困难、消化不良等疾病。经常食用沙棘制成品,可增进人的心肌功能,治愈胸闷和气短等症状,与降压药合用有协调作用,可降低血胆固醇和甘油三脂。沙棘油是良好的外伤药,可用于治疗烧伤、冻伤和各种皮炎。
据营养学家化验测定,沙棘果中除含有丰富的蛋白质、脂肪和碳水化合物外,还含有人体必需的多种维生素和矿物质。其中维生素C(抗坏血酸)、E(生育粉)、A(胡萝卜素)、K的含量,几乎居一切果蔬之冠。尤以维生素C的含量最高,每百克沙棘果中含量达800—850毫克,高的可达2100毫克,比猕猴桃高3—4倍,比桔子高10—15倍,相当于山楂果的20倍,葡萄的200倍。沙棘果中所含11%的脂肪(籽油中含4%)沙棘油是脂肪酸甘油脂,有棕榈酸、油酸、亚油酸、亚麻酸等18种脂酸的混合物,大部分为不饱和脂肪酸,及易被人体吸收,并能降低血液中的脂固醇和甘油三脂,可有效地防治动脉粥样硬化和冠心病。
白刺具有健脾胃、滋补强壮,调经活血,催乳之功效。常用于脾胃虚弱,消化不良,神经衰弱,高血压头晕,感冒,乳汁不下。白刺果实中除了含有糖类、蛋白质、维生素、膳食纤维、微量元素等常量营养物质之外,还含有多种生物活性物质,主要是植物化学物。就降血糖活性作用而言,从天然植物中提取的对高血糖具有抑制或调节的有八大类,按其化学结构可分为:萜类、黄酮类、多糖类、甾体类、胰岛素、肽、氨基酸类、不饱和脂肪酸类、生物碱类、硫键化合物类。而在白刺果实中发现了其中的7类。其中包括白刺多糖、白刺总黄酮等。白刺还具有降血脂、预防冠心病等功效,其中的黄酮类物质发挥了极其重要的作用。白刺具有降低高血压,缓解头晕、头痛的作用,其中含有的卡波林类生物碱被认为是主要的功能物质。白刺中的尿囊素,具有麻醉、镇痛、抗刺激性作用,并且还具有刺激组织生长,促进细胞繁殖,加快伤口愈合,软化角质层蛋白等生理功能和增殖作用,可广泛用于生产治疗糖尿病、肝硬化及癌症等的多种药物。
燕麦具有降低血压、降低胆固醇、纺织大肠癌、防治心脏疾病的作用。燕麦中的β-葡聚糖可减缓血液中葡萄糖含量的增加,预防和控制肥胖症、糖尿病及心血管疾病。燕麦富含的膳食纤维具有清理肠道垃圾的作用,对于因肝、肾病变,糖尿病,脂肪肝等引起的继发性高脂血症有明显疗效,也有利于糖尿病和肥胖病的控制。燕麦既兼顾营养又控制发胖,是心脑血管病人群、肝肾功能不全者、肥胖者、中年人、减肥瘦身女性的保健佳品,适宜脂肪肝、糖尿病、浮肿、习惯性便秘者食用;还适宜体虚自汗、多汗、易汗、盗汗者食用;特别适宜高血压病、高脂血症、动脉硬化者食用。
菊粉是菊苣根茎粉末,菊苣是一种富含膳食纤维的健康食品,属于“益生元”。菊粉中的膳食纤维分为两种,一种是可溶性的β—葡聚糖,另一种是不可溶性的粗纤维。前者容易在肠道中被细菌所降解,产生短链脂肪酸等一系列有益于人体的代谢产物;后者则不容易被消化酶降解,更多起到了促进肠道蠕动的作用。菊苣中还富含锰、铜、钙、钾、镁、磷等矿物元素,以及丰富的生物碱类物质,是高尿酸人群的健康调理佳品。
青稞下气宽中、壮精益力、除湿发汗、止泻,含有丰富的蛋白质和维生素,具有补脾养胃、益气止泻的功效,适合脾胃气虚、倦怠无力者食用。
藜麦富含多种矿物质和优质的高纤维碳水化合物,高纤维碳水化合物消化缓慢,可以保障餐后血糖水平不会升高太多,减少糖尿病并发症的几率。藜麦还是零胆固醇食物,富含植源性多不饱和脂肪酸,不仅能促进神经和脑细胞发育,还显著降低血液胆固醇、三酸甘油脂和血液黏稠度,增加胰岛组织β细胞活性,广泛用于抑制高血压、高血脂、糖尿病、心脏病、老年痴呆、抑郁症、慢性病等,对抑制癌症和增强免疫也效果显著。
豌豆和黄豆都富含丰富的蛋白质和粗纤维,豌豆中所含有的胆碱、蛋氨酸有助于防止动脉硬化,止杈酸、赤霉素和植物凝集素等物质,具有抗菌消炎、增强新陈代谢的功效。黄豆含有很多不饱和脂肪酸,容易被人体吸收,黄豆中还含有大量的膳食纤维,对促进良好的消化和排泄固体废物有重要作用,防止便秘,而且能明显降低血浆胆固醇、调节胃肠功能及胰岛素水平。
本发明使用青藏高原的沙棘鲜果、白刺果和藜麦等高原植物资源,使配方中膳食纤维、植物多糖的比例更高,可以更好地促进人体的新陈代谢;本发明配方中淀粉、糖等高能量原料占比较低,氨基酸和微量元素的比例相对较高,有利于肠道健康;同时本发明配方中花色苷、植物多糖等有益物质丰富,可以提升抗氧化水平,促进机体新陈代谢,从而全面提升身体机能。
本发明所具有的有益效果:本发明是以青藏高原出产的是沙棘鲜果为主料,以白刺干果、藜麦、青稞、燕麦、豌豆、黄豆和菊粉为辅助原料制成,本发明能够增加食物中的膳食纤维、不饱和脂肪酸、植物多糖等,能提高食用者的饱腹感,控制能量摄入,进而较好地管理体重,提升健康水平。
具体实施方式
下面结合具体实施例对本发明作进一步的说明。
实施例1
称取沙棘鲜果300g,白刺干果120g,藜麦300g,青稞150g,燕麦70g,豌豆150g,黄豆120g,菊粉40g。
将沙棘鲜果送入压榨机中压榨打浆,果皮、果籽留在过滤袋中,果浆则流入果浆桶。将沙棘果浆送入降膜蒸发器中,沙棘果汁被浓缩,将沙棘浓缩浆导入配料搅拌缸;向配料搅拌缸内加入麦芽糊精,麦芽糊精的添加量占沙棘浓缩浆的1/4;打开蒸汽阀门向配料缸夹层通入蒸汽,同时启动搅拌机搅拌液料;当液料温度升到80℃后,持续搅拌30分钟,直到麦芽糊精全部溶解;将沙棘麦芽糊精混合浆料导入喷雾干燥机,将进风温度设定为150℃,出口温度设定为 100℃;沙棘果粉的粒径为40微米。
将白刺果送入复水搅拌罐中搅拌浸泡30分钟;将复水后的白刺果导入压榨机后,启动螺旋压榨机将白刺果浆挤出;白刺果籽、白刺果皮则被收集起来。将盛有白刺果浆的料盘送入降膜蒸发器中浓缩,温度保持在50℃。将白刺浓缩果浆倒入有沿料盘,料液的厚度为2厘米,料盘放在冷冻干燥机内;关闭冷冻仓,然后把冷冻干燥机的真空度调至0.4帕,将果浆水分降至5%。将白刺果浆冷冻块料送入粉碎机粉碎,然后过40目振动筛筛分,最后得到白刺果冻干粉,粉体粒径40微米。
将沙棘果皮、沙棘果籽、白刺果皮、白刺果籽烘干,送入超微粉碎机进行粉碎,得到沙棘白刺混合膳食纤维粉,粉体粒径20微米。
将藜麦米用高效粉碎机加工至60微米的颗粒;将藜麦粉置于高压蒸煮锅里加水搅拌均匀,高压蒸煮30分钟;将糊化熟透的藜麦浆送入高压均质机研磨,得到藜麦米浆;将藜麦米浆送入压力式喷雾干燥机喷雾干燥,得到藜麦熟化粉,粒径为40微米。
将燕麦和青稞混合后送入高效粉碎机,将混合物粉碎至30微米;将粉碎后的燕麦青稞混合粉送入混合调质机内,喷洒占总量15%的洁净水闷润;将闷润后的混合粉送入膨化机中,开动膨化机将混合粉膨化、粉碎,加工成为直径10毫米、长8毫米的混合谷物膨化颗粒;将混合谷物膨化颗粒送入高效粉碎机,加工成直径40微米的燕麦青稞混合膨化粉;膨化后的粉体被迅速熟化。把燕麦、青稞混合均匀,一同加工,可以提高膨化效率,提升质量。
将豌豆、黄豆混合后送入电动磨,进行超细研磨后过滤,得到豌豆黄豆混合浆和豌豆黄豆混合渣;将豌豆黄豆混合浆导入喷雾干燥机,得到豌豆黄豆复合速溶粉;豌豆黄豆复合速溶粉的粒径40微米。将豌豆黄豆混合渣送入微波干燥机进行干燥,将干燥后的混合豆渣送入超微粉碎机研磨,得到豌豆黄豆复合膳食纤维粉,其粒径为20微米。
将沙棘果粉、白刺果粉、沙棘白刺复合膳食纤维粉、藜麦熟化粉、青稞燕麦混合膨化粉、豌豆黄豆膳食纤维粉与菊粉混合均匀,制得沙棘白刺藜麦代餐粉。
加工好的沙棘白刺藜麦代餐粉成品物理性质稳定,外观呈粉末状,颜色为黄褐色,膳食纤维含量高达16%,粉体粒径分布合理,质地疏松柔软,不粘不重, pH值呈微碱性,含水率约为5%,口感酸甜适口,是体重管理的优良食品。
实施例2
称取沙棘鲜果120g,白刺干果60g,藜麦160g,青稞50g,燕麦40g,豌豆 80g,黄豆80,菊粉20g。
将沙棘鲜果送入压榨机中压榨打浆,果皮、果籽留在过滤袋中,果浆则流入果浆桶。将沙棘果浆送入降膜蒸发器中,沙棘果汁被浓缩,将沙棘浓缩浆导入配料搅拌缸;向配料搅拌缸内加入麦芽糊精,麦芽糊精的添加量占沙棘浓缩浆的1/4;打开蒸汽阀门向配料缸夹层通入蒸汽,同时启动搅拌机搅拌液料;当液料温度升到80℃后,持续搅拌30分钟,直到麦芽糊精全部溶解;将沙棘麦芽糊精混合浆料导入喷雾干燥机,将进风温度设定为140℃,出口温度设定为90℃;沙棘果粉的粒径为30微米。
将白刺果送入复水搅拌罐中搅拌浸泡30分钟;将复水后的白刺果导入压榨机后,启动螺旋压榨机将白刺果浆挤出;白刺果籽、白刺果皮则被收集起来。将盛有白刺果浆的料盘送入降膜蒸发器中浓缩,温度保持在50℃。将白刺浓缩果浆倒入有沿料盘,料液的厚度为2厘米,料盘放在冷冻干燥机内;关闭冷冻仓,然后把冷冻干燥机的真空度调至0.2帕,将果浆水分降至4.5%。将白刺果浆冷冻块料送入粉碎机粉碎,然后过40目振动筛筛分,最后得到白刺果冻干粉,粉体粒径30微米。
将沙棘果皮、沙棘果籽、白刺果皮、白刺果籽烘干,送入超微粉碎机进行粉碎,得到沙棘白刺混合膳食纤维粉,粉体粒径10微米。
将藜麦米用高效粉碎机加工至40微米的颗粒;将藜麦粉置于高压蒸煮锅里加水搅拌均匀,高压蒸煮30分钟;将糊化熟透的藜麦浆送入高压均质机研磨,得到藜麦米浆;将藜麦米浆送入压力式喷雾干燥机喷雾干燥,得到藜麦熟化粉,粒径为30微米。
将燕麦和青稞混合后送入高效粉碎机,将混合物粉碎至30-40微米;将粉碎后的燕麦青稞混合粉送入混合调质机内,喷洒占总量13%的洁净水闷润;将闷润后的混合粉送入膨化机中,开动膨化机将混合粉膨化、粉碎,加工成为直径8 毫米、长7毫米的混合谷物膨化颗粒;将混合谷物膨化颗粒送入高效粉碎机,加工成直径30微米的燕麦青稞混合膨化粉;膨化后的粉体被迅速熟化。把燕麦、青稞混合均匀,一同加工,可以提高膨化效率,提升质量。
将豌豆、黄豆混合后送入电动磨,进行超细研磨后过滤,得到豌豆黄豆混合浆和豌豆黄豆混合渣;将豌豆黄豆混合浆导入喷雾干燥机,得到豌豆黄豆复合速溶粉;豌豆黄豆复合速溶粉的粒径40微米。将豌豆黄豆混合渣送入微波干燥机进行干燥,将干燥后的混合豆渣送入超微粉碎机研磨,得到豌豆黄豆复合膳食纤维粉,其粒径为10微米。
将沙棘果粉、白刺果粉、沙棘白刺复合膳食纤维粉、藜麦熟化粉、青稞燕麦混合膨化粉、豌豆黄豆膳食纤维粉与菊粉混合均匀,制得沙棘白刺藜麦代餐粉。
加工好的沙棘白刺藜麦代餐粉成品物理性质稳定,外观呈粉末状,颜色为黄褐色,膳食纤维含量高达19%,粉体粒径分布合理,质地疏松柔软,不粘不重, pH值呈微碱性,含水率约为4%,口感酸甜适口,是体重管理的优良食品。
实施例3
称取沙棘鲜果200g,白刺干果100g,藜麦300g,青稞100g,燕麦80g,豌豆120g,黄豆120g,菊粉30g。
将沙棘鲜果送入压榨机中压榨打浆,果皮、果籽留在过滤袋中,果浆则流入果浆桶。将沙棘果浆送入降膜蒸发器中,沙棘果汁被浓缩,将沙棘浓缩浆导入配料搅拌缸;向配料搅拌缸内加入麦芽糊精,麦芽糊精的添加量占沙棘浓缩浆的1/4;打开蒸汽阀门向配料缸夹层通入蒸汽,同时启动搅拌机搅拌液料;当液料温度升到80℃后,持续搅拌30分钟,直到麦芽糊精全部溶解;将沙棘麦芽糊精混合浆料导入喷雾干燥机,将进风温度设定为150℃,出口温度设定为95℃;沙棘果粉的粒径为30微米。
将白刺果送入复水搅拌罐中搅拌浸泡30分钟;将复水后的白刺果导入压榨机后,启动螺旋压榨机将白刺果浆挤出;白刺果籽、白刺果皮则被收集起来。将盛有白刺果浆的料盘送入降膜蒸发器中浓缩,温度保持在50℃。将白刺浓缩果浆倒入有沿料盘,料液的厚度为2厘米,料盘放在冷冻干燥机内;关闭冷冻仓,然后把冷冻干燥机的真空度调至0.3帕,将果浆水分降至4%。将白刺果浆冷冻块料送入粉碎机粉碎,然后过40目振动筛筛分,最后得到白刺果冻干粉,粉体粒径40微米。
将沙棘果皮、沙棘果籽、白刺果皮、白刺果籽烘干,送入超微粉碎机进行粉碎,得到沙棘白刺混合膳食纤维粉,粉体粒径10微米。
将藜麦米用高效粉碎机加工至50微米的颗粒;将藜麦粉置于高压蒸煮锅里加水搅拌均匀,高压蒸煮30分钟;将糊化熟透的藜麦浆送入高压均质机研磨,得到藜麦米浆;将藜麦米浆送入压力式喷雾干燥机喷雾干燥,得到藜麦熟化粉,粒径为30微米。
将燕麦和青稞混合后送入高效粉碎机,将混合物粉碎至30微米;将粉碎后的燕麦青稞混合粉送入混合调质机内,喷洒占总量11%的洁净水闷润;将闷润后的混合粉送入膨化机中,开动膨化机将混合粉膨化、粉碎,加工成为直径9毫米、长7毫米的混合谷物膨化颗粒;将混合谷物膨化颗粒送入高效粉碎机,加工成直径30微米的燕麦青稞混合膨化粉;膨化后的粉体被迅速熟化。把燕麦、青稞混合均匀,一同加工,可以提高膨化效率,提升质量。
将豌豆、黄豆混合后送入电动磨,进行超细研磨后过滤,得到豌豆黄豆混合浆和豌豆黄豆混合渣;将豌豆黄豆混合浆导入喷雾干燥机,得到豌豆黄豆复合速溶粉;豌豆黄豆复合速溶粉的粒径40微米。将豌豆黄豆混合渣送入微波干燥机进行干燥,将干燥后的混合豆渣送入超微粉碎机研磨,得到豌豆黄豆复合膳食纤维粉,其粒径为10微米。
将沙棘果粉、白刺果粉、沙棘白刺复合膳食纤维粉、藜麦熟化粉、青稞燕麦混合膨化粉、豌豆黄豆膳食纤维粉与菊粉混合均匀,制得沙棘白刺藜麦代餐粉。
加工好的沙棘白刺藜麦代餐粉成品物理性质稳定,外观呈粉末状,颜色为黄褐色,膳食纤维含量高达20%,粉体粒径分布合理,质地疏松柔软,不粘不重, pH值呈微碱性,含水率约为4.6%,口感酸甜适口,是体重管理的优良食品。
实施例4
体重管理的临床治疗实验
实验材料:实施例1、实施例2和实施例3所制得的代餐粉。
实验对象:150位肥胖的亚健康人群。
实验方法:将实验对象随机分成A、B、C三个实验组,每个实验组50人。向A、B、C三组分别提供实施例1、实施例2和实施例3制备的代餐粉服用,连续服用30天,每天服用3次代餐粉,用于代替早、中、晚三餐。每次服用35g,将35g代餐粉溶于250毫升的热牛奶中搅拌均匀后服用。
功效判断
显效:体重明显下降5公斤以上,食用后饱腹感明显。
有效:体重下降1-5公斤,食用后有饱腹感。
无效:体重未有明显变化,与不用该产品的差距不大,食用后没有饱腹感。
实验结果:详见表1
表1清理肠道的临床治疗实验结果
分组 | 显效(例) | 有效(例) | 无效(例) |
A组 | 22 | 28 | 0 |
B组 | 20 | 30 | 0 |
C组 | 24 | 26 | 0 |
从表1可以看出,本发明实施例1、2、3制备的代餐粉能减少糖类、淀粉类的摄入,增加膳食纤维的摄入,明显提高体重管理效果。
本发明的说明书被认为是说明性的而非限制性的,在本发明基础上,本领域技术人员根据所公开的技术内容,不需要创造性的劳动就可以对其中一些技术特征做出一些替换和变形,均在本发明的保护范围内。
Claims (3)
1.一种沙棘白刺藜麦代餐粉,其特征在于,由以下原料组成:沙棘鲜果、白刺果、藜麦、青稞、燕麦、豌豆、黄豆和菊粉。
2.根据权利要求1所述的一种沙棘白刺藜麦代餐粉,其特征在于,由以下重量份的原料组成:沙棘鲜果4-30份,白刺果5-15份,藜麦15-35份,青稞5-15份,燕麦3-8份,豌豆8-15份,黄豆8-15份,菊粉2-5份。
3.根据权利要求2所述的一种沙棘白刺藜麦代餐粉的制备方法,其特征在于,包括以下步骤:
A、按照重量份称取各原料组分;
B、将沙棘鲜果打浆,压榨,过滤得到沙棘果浆和沙棘籽皮;将沙棘果浆浓缩,喷雾干燥,得到沙棘果粉;
C、将白刺干果浸泡复水,压榨,均质,过滤,得到白刺果浆和白刺籽皮;将白刺果浆浓缩,冷冻干燥并粉碎,得到白刺果粉;
D、将步骤B中的沙棘籽皮和步骤C中的白刺籽皮混合进行干燥,超微粉碎,得到沙棘白刺复合膳食纤维粉;
E、将藜麦磨浆,高压蒸煮,喷雾干燥,得到藜麦熟化粉;
F、将青稞和燕麦混合后粉碎,将粉碎后的混合物膨化加工,获得混合膨化粉,再粉碎成粒径为40-60微米的青稞燕麦混合膨化粉;
G、将黄豆和豌豆混合,浸泡,磨浆,均质,过滤,得到豌豆黄豆混合浆和豌豆黄豆混合渣;将豌豆黄豆混合浆喷雾干燥,得到粒径为30-40微米的豌豆黄豆复合速溶粉;将豌豆黄豆混合渣微波干燥,超微粉碎,得到粒径为10-20微米的豌豆黄豆膳食纤维粉;
H、将步骤B中的沙棘果粉、步骤C中的白刺果粉、步骤D中的沙棘白刺复合膳食纤维粉、步骤E中的藜麦熟化粉、步骤F中的青稞燕麦混合膨化粉、步骤G中的豌豆黄豆膳食纤维粉与菊粉混合均匀,制得沙棘白刺藜麦代餐粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910776238.6A CN110547461A (zh) | 2019-08-22 | 2019-08-22 | 一种沙棘白刺藜麦代餐粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910776238.6A CN110547461A (zh) | 2019-08-22 | 2019-08-22 | 一种沙棘白刺藜麦代餐粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110547461A true CN110547461A (zh) | 2019-12-10 |
Family
ID=68737798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910776238.6A Pending CN110547461A (zh) | 2019-08-22 | 2019-08-22 | 一种沙棘白刺藜麦代餐粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110547461A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112262987A (zh) * | 2020-10-30 | 2021-01-26 | 浙江惠宝生物科技有限公司 | 发酵膳食纤维复配益生菌代餐粉 |
CN114424818A (zh) * | 2022-01-30 | 2022-05-03 | 甘肃慧联信息科技发展有限责任公司 | 一种基于苹果的低卡路里代餐营养棒及其制备方法 |
CN115500460A (zh) * | 2022-08-17 | 2022-12-23 | 贵州雍福产业发展投资(集团)有限公司 | 一种富含氨基酸豆腐乳的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143154A (zh) * | 2007-05-28 | 2008-03-19 | 胡坪 | 表面包覆超微中药饮片的制备方法 |
CN102526124A (zh) * | 2011-01-31 | 2012-07-04 | 成都科尔医药技术有限公司 | 一种中药粉体及其制备方法 |
CN108185288A (zh) * | 2017-12-29 | 2018-06-22 | 广东粤微食用菌技术有限公司 | 一种全营养健胃代餐米稀及其制备方法和使用方法及用途 |
-
2019
- 2019-08-22 CN CN201910776238.6A patent/CN110547461A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143154A (zh) * | 2007-05-28 | 2008-03-19 | 胡坪 | 表面包覆超微中药饮片的制备方法 |
CN102526124A (zh) * | 2011-01-31 | 2012-07-04 | 成都科尔医药技术有限公司 | 一种中药粉体及其制备方法 |
CN108185288A (zh) * | 2017-12-29 | 2018-06-22 | 广东粤微食用菌技术有限公司 | 一种全营养健胃代餐米稀及其制备方法和使用方法及用途 |
Non-Patent Citations (1)
Title |
---|
鸿蒙大健康: "减养 黑枸杞白刺青稞代餐粉", 《HTTPS://WWW.MEIPIAN.CN/2A14NLRT》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112262987A (zh) * | 2020-10-30 | 2021-01-26 | 浙江惠宝生物科技有限公司 | 发酵膳食纤维复配益生菌代餐粉 |
CN114424818A (zh) * | 2022-01-30 | 2022-05-03 | 甘肃慧联信息科技发展有限责任公司 | 一种基于苹果的低卡路里代餐营养棒及其制备方法 |
CN115500460A (zh) * | 2022-08-17 | 2022-12-23 | 贵州雍福产业发展投资(集团)有限公司 | 一种富含氨基酸豆腐乳的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101564161B (zh) | 高血脂高血糖患者专用的营养保健食品及其制备方法 | |
CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
CN102726799A (zh) | 一种既可完善饮食结构又可调理饮食性味的纯天然饮品 | |
WO2010025605A1 (zh) | 纳米功能健康食品及其加工方法 | |
CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
CN110547461A (zh) | 一种沙棘白刺藜麦代餐粉及其制备方法 | |
CN110771825A (zh) | 一种用于减脂、降血糖、降血压和降血脂的综合营养粉及其制备方法 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
KR101627837B1 (ko) | 말뼈 추출물과 해마를 주성분으로 포함하는 건강보조식품 및 그의 제조방법 | |
CN111096416A (zh) | 用于减肥代餐的断食组合物及其制备方法 | |
CN109349421A (zh) | 一种肉鸽促生长生态饲料及其制备方法 | |
CN110583974A (zh) | 一种瘦身全谷营养健康代餐食品及其制备方法 | |
CN110547450A (zh) | 一种枸杞白刺燕麦代餐粉及其制备方法 | |
CN104187448A (zh) | 一种多功能保健豆粉 | |
CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
CN111671077A (zh) | 一种含有亚麻木酚素的全营养代餐粉及其制备方法 | |
CN111109518A (zh) | 一种具有降血脂功效的杂粮饭及其制备方法 | |
CN110547462A (zh) | 一种白刺莴笋燕麦代餐粉及其制备方法 | |
CN109007814A (zh) | 适用于糖尿病、脂代谢异常、肥胖症、便秘和痛风人群的营养组合物及其制备方法和应用 | |
CN110547463A (zh) | 一种菊苣白刺青麦代餐粉及其制备方法 | |
CN110801029A (zh) | 一种清肠通便的青稞代餐粉及其制备方法 | |
CN103689561A (zh) | 一种有助于降脂减肥的养生保健食品配方及其制备方法 | |
CN112998115A (zh) | 一种排油减肥的压片果糖及其制备方法 | |
CN110547451A (zh) | 一种黑枸杞白刺青稞代餐粉及其制备方法 | |
CN109965199A (zh) | 一种药食同源营养代餐粉及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191210 |